A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Clinical trial NCT00545129 · COMPLETED
Trial details
- NCT number
- NCT00545129
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-29
- Primary completion
- 2011-12-24
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.